BVMF/R1DY34 (BVMF/R1DY34)

Brazil Stock Exchange: BVMF/R1DY34 · BRL

R$12.3

+0.00 (0.0%)· Recorded snapshot

Market cap	62.9B
Revenue (ttm)	17.8B
Net income (ttm)	1.5B
EPS (ttm)	R$1.89
P/E (trailing)	6.5x
P/E (forward)	25.7x
Dividend	R$0.05 (0.43%)
Volume	8
Beta	0.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.8B
Net income (ttm): 1.5B
EPS (ttm): R$1.89
P/E (trailing): 6.5x
P/E (forward): 25.7x
Market cap: 62.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E25.7

P25 n/aP50 n/aP75 n/a

Trailing P/E6.5

P25 n/aP50 n/aP75 n/a

ROE7.3

P25 n/aP50 n/aP75 n/a

ROIC6.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/R1DY34 indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

INR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-10-23
Employees	27,527
Employees change	-284
Employees growth	-1.02%
Enterprise value	BRL 62.9B
Exchange	Brazil Stock Exchange
Financial currency	INR
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	March
Founded	1984
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	BRR1DYBDR008
Last earnings date	2026-10-23
Last refreshed	2026-10-29
Last stock split date	2024-11-05
Last stock split type	Forward
Market cap	BRL 62.9B
Next earnings date	2026-10-30
Price	BRL 12.34
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/R1DY34

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	28.75x
Average P/E ratio (3Y)	22.15x
Average P/E ratio (5Y)	22.38x
Earnings yield	15.34%
EV/Earnings	41.58x
EV/EBIT	37.06x
EV/EBITDA	21.64x
EV/FCF	84.07x
EV/Sales	3.38x
FCF / EV yield	1.19%
FCF yield	1.19%
Forward P/E	25.72x
Graham number	5.2474
Graham upside	-57.48%
Lynch fair value	BRL 2.24
Lynch upside	-81.86%
P/(FCF - SBC) ratio	86.05x
P/(OCF - SBC) ratio	38.05x
P/B ratio	2.99x
P/E ratio	6.52x
P/FCF ratio	84.12x
P/OCF ratio	37.67x
P/S ratio	3.53x
Price / tangible book value	4.33x
Price/EBITDA ratio	23.39x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.11%
EBITDA margin	15.1%
Effective tax rate	21.69%
FCF margin	4.02%
Gross margin	49.49%
Operating margin	9.11%
Pretax margin	10.68%
Profit margin	8.48%
Profit per employee	BRL 54,924
Revenue per employee	BRL 647,336
ROA	3.37%
ROA (5Y)	9.28%
ROCE	7.16%
ROE	7.34%
ROE (5Y)	17.3%
ROIC	6.17%
ROIC (5Y)	18.57%
SBC / revenue	0.09%
Tax / revenue	2.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-52.23%
EPS growth (Q)	-35.65%
EPS growth (QoQ)	108.65%
EPS growth 10Y	10.23%
EPS growth 3Y	-18.09%
EPS growth 5Y	7.5%
FCF growth	-56.58%
FCF growth (Q)	-72.14%
FCF growth 3Y	-38.42%
FCF growth 5Y	24.27%
Gross profit growth	-15.46%
Gross profit growth (Q)	-6.1%
Gross profit growth 3Y	1.52%
Gross profit growth 5Y	8.53%
Net income growth	-52.26%
Net income growth (Q)	-35.64%
Net income growth (QoQ)	108.57%
Net income growth 3Y	-18.07%
Net income growth 5Y	7.55%
OCF growth	-47.45%
OCF growth (Q)	-66.07%
OCF growth 10Y	0.63%
OCF growth 3Y	-24.6%
OCF growth 5Y	12.45%
Operating income growth	-57.92%
Operating income growth (Q)	-28.53%
Operating income growth 3Y	-22.35%
Operating income growth 5Y	-2.03%
Revenue growth	-3.6%
Revenue growth (Q)	-1.53%
Revenue growth (QoQ)	7.44%
Revenue growth 10Y	8.63%
Revenue growth 3Y	7.32%
Revenue growth 5Y	10.15%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -922.1M
Depreciation and amortization	BRL 1.1B
EBIT	BRL 1.6B
EBITDA	BRL 2.7B
EPS	BRL 1.89
Financing cash flow	BRL 7M
Free cash flow	BRL 747.8M
Free cash flow minus SBC	BRL 731M
Gross profit	BRL 8.8B
Income taxes	BRL 412.7M
Investing cash flow	BRL -1.5B
Net borrowing	BRL 638.5M
Net cash flow	BRL 177.4M
Net income	BRL 1.5B
Operating cash flow minus SBC	BRL 1.7B
Operating income	BRL 1.6B
Revenue	BRL 17.8B
Stock-based compensation	BRL 16.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.29
Book value per share	BRL 25.04
Debt / EBITDA	1.4
Debt / equity	0.19
Debt / FCF	5.22
Goodwill	BRL 731.9M
Interest coverage	6.67
Long-term assets	BRL 14.3B
Long-term liabilities	BRL 1.3B
Net cash (debt)	BRL 213.7M
Net cash / market cap	0.34%
Net cash growth	-64.92%
Net debt / EBITDA	-0.08
Net debt / equity	-0.01
Net debt / FCF	-0.29
Piotroski F-Score	5
Property, plant and equipment	BRL 6.5B
Shareholders' equity	BRL 21B
Tangible book value	BRL 14.5B
Tangible book value per share	BRL 17.45
Total assets	BRL 31B
Total cash	BRL 4.1B
Total debt	BRL 3.9B
Total liabilities	BRL 10B
WACC	5.58%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.59
Current assets	BRL 16.8B
Current liabilities	BRL 8.7B
Current ratio	1.93
Inventory turnover	2.12
Net working capital	BRL 6.9B
Quick ratio	1.15
Working capital	BRL 7.7B
Working capital turnover	0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.05%
Dividend growth	-16.01%
Dividend growth (3Y)	-6.83%
Dividend growth years	0
Dividend payment date	2026-08-11
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BRL 0.05
Dividend yield	0.43%
Ex-dividend date	2026-07-08
Last dividend	BRL 0.05
Payout ratio	23.81%
Shareholder yield	0.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	15.33%
1M total return	15.33%
1W price change	11.57%
1W total return	11.57%
1Y price change	-2.06%
1Y return CAGR	-1.64%
1Y total return	-1.63%
20-day SMA	BRL 11.27
3M price change	1.98%
3M total return	2.43%
3Y price change	10.85%
3Y return CAGR	4%
3Y total return	12.49%
50-day SMA	BRL 12.10
52-week high	BRL 12.81
52-week high date	2026-06-29
52-week low	BRL 10.03
52-week low date	2026-10-08
6M price change	12.59%
6M total return	13.09%
All-time high	BRL 16.34
All-time high date	2024-07-29
All-time low	BRL 9.10
All-time low date	2023-01-12
Average true range (ATR)	BRL 0.44
Average volume	215.6
Beta (5Y)	0.25
Change from 52-week high	-3.67%
Change from 52-week low	23.03%
Change from all-time high	-24.49%
Change from all-time low	35.57%
Change from open	1.98%
Dollar volume	BRL 98.72
High price	BRL 12.35
Low price	BRL 12.10
Monthly RSI	54.13
Open price	BRL 12.10
Position in 52-week range	96%
Price vs 20-day SMA	9.49%
Price vs 50-day SMA	1.95%
Relative volume	0.04
RSI	57.54
Sharpe ratio	1.09
Sortino ratio	1.99
Volume	8
Weekly RSI	51.09
YTD price change	3.18%
YTD total return	3.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	600.1M
Shares change (QoQ)	-0.04%
Shares change (YoY)	-0.05%
Shares held by insiders	26.72%
Shares held by institutions	57.64%

Deeper analysis on BVMF/R1DY34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/R1DY34 report

Is a complete BVMF/R1DY34 research report available?

No complete published report is available for bvmf/R1DY34 (BVMF/R1DY34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/R1DY34 (BVMF/R1DY34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/R1DY34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/R1DY34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/R1DY34

Frequently asked questions